MedPath

hydrocortisone and acetic acid

Hydrocortisone and Acetic Acid Otic Solution, USP

Approved
Approval ID

ffd1edc1-2f40-4b0a-a53a-9fb53b8d3184

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Oct 13, 2022

Manufacturers
FDA

Akorn Operating Company LLC

DUNS: 117696873

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

hydrocortisone and acetic acid

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code50383-901
Application NumberNDA012770
Product Classification
M
Marketing Category
C73594
G
Generic Name
hydrocortisone and acetic acid
Product Specifications
Route of AdministrationAURICULAR (OTIC)
Effective DateOctober 13, 2022
FDA Product Classification

INGREDIENTS (7)

ACETIC ACIDActive
Quantity: 20.75 mg in 1 mL
Code: Q40Q9N063P
Classification: ACTIB
ANHYDROUS CITRIC ACIDInactive
Code: XF417D3PSL
Classification: IACT
BENZETHONIUM CHLORIDEInactive
Code: PH41D05744
Classification: IACT
PROPYLENE GLYCOLInactive
Code: 6DC9Q167V3
Classification: IACT
PROPYLENE GLYCOL DIACETATEInactive
Code: 5Z492UNF9O
Classification: IACT
SODIUM ACETATEInactive
Code: 4550K0SC9B
Classification: IACT
HYDROCORTISONEActive
Quantity: 10.375 mg in 1 mL
Code: WI4X0X7BPJ
Classification: ACTIB

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

hydrocortisone and acetic acid - FDA Drug Approval Details